冠状动脉内支臂疗法对静脉静脉复原的结果
Thomas R Basala1, Muhmmad S Khalid2, Ozgur Selim Ser3
1The Center for Coronary Artery Disease, Minneapolis Heart Institution Foundation and Minneapolis Heart Institute, Minneapolis, Minnesota; The University of Michigan Medical School, Ann Arbor, Michigan.
The American journal of cardiology
|March 29, 2025
概括
针对静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉静脉 较高的辐射剂量降低了失败风险,而重复治疗增加了失败风险,突出了剂量优化和重新治疗方面的考虑.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 辐射瘤学 辐射瘤学
背景情况:
- 内冠状动脉支臂疗法 (ICBT) 仍然是治疗静脉静脉复缩 (ISR) 的一种选择,因为替代方案有限.
- 在冠状动脉疾病的管理中,静脉静脉复杂的存在复杂的挑战.
研究的目的:
- 评估ICBT对ISR的指示,患者特征和临床结果.
- 在ICBT后识别影响目标病变衰竭 (TLF) 的因素.
主要方法:
- 在2014年至2023年期间,对343名接受ICBT治疗的患者进行了502次ISR病变的回顾性分析.
- 对TLF预测器的技术成功,长期跟进和多变量分析的评估.
主要成果:
- 技术上的成功率很高 (96.1%). 三年TLF的发病率为36.4%.
- 较高的辐射剂量与较低的TLF风险相关 (每10 Gy的aHR:0.73).
- 重复ICBT程序显示,与首次治疗相比,3年TLF发生率显著更高 (p = 0.008).
结论:
- 对于ISR,ICBT后的3年TLF利率相当高,为36.4%.
- 优化辐射剂量和仔细考虑重复ICBT程序对于改善患者的治疗结果至关重要.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
01:28Acute Coronary Syndrome IV: Interprofessional Care
525
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525